[18F] FDG PET/CT in patients with fever of unknown origin: A local experience

Nuclear Medicine Communications

Volumn 31, Issue 9, 2010, Pages 788-792

  Keia, Pin Lin ^a,b   Koka, Tian Yue ^a   Padhya, Ajit K ^a   Nga, David C ^a   Goha, Anthony S ^a  

^a Departments of Nuclear Medicine and PET   (Australia)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

18F FDG PET; Fever of unknown origin; PET CT; Pyrexia

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DATA BASE; DISEASE DURATION; EVALUATION; FEMALE; HUMAN; IMAGING; INFLAMMATORY DISEASE; LYMPHOMA; MALE; NEOPLASM; PANCREATITIS; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; THYROIDITIS; COMPUTER ASSISTED TOMOGRAPHY; FACTUAL DATABASE; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING;

AGED; DATABASES, FACTUAL; FEMALE; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956882081     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833d0281     Document Type: Article

References (20)

1. Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992; 152:21-22.
2. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961; 40:1-30.
3. Durack DT, Street AC. Fever of unknown origin - reexamined and redefined. Curr Clin Top Infect Dis 1991; 11:35-51.
4. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30:150-185.
5. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
6. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995; 36:1854-1861.
7. Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 2004; 15:151-156. (Pubitemid 38900559)
8. 18F-FDG PET and 111Ingranulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004; 31:622-626. (Pubitemid 38647899)
9. Kalicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M, et al. Fluorine- 18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27:524-528.
10. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191-196.
11. 18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 27:1617-1625.
12. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007; 48:35-45.
13. Balink H, Collins J, Bruyn G, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med 2009; 34:862-868.
14. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001; 22:779-783.
15. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, Van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31:29-37.
16. Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25:1238-1243.
17. Rennen HJ, Laverman P, van Eerd JE, Oyen WJ, Corstens FH, Boerman OC. PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. Nucl Med Biol 2007; 34:691-695.
18. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, Reske SN. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39:2145-2152.
19. DeWinter F, van de Wiele C, Vogelaers D, de Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83:651-660.
20. Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25:281-284.